Navigation Groupe de Recherche en Economie Théorique et Appliquée (GREThA) - UMR 5113 par Auteur "USECHE, Diego"
-
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms
USECHE, Diego; POMMET, Sophie(Small Business Economics. vol. 57, n° 3, pp. 1339-1359, 2021)Article de revue -
Highly skilled and well connected: Migrant inventors in cross-border M&As
USECHE, Diego; MIGUELEZ, Ernest; LISSONI, Francesco(Journal of International Business Studies. vol. 51, pp. 737–763, 2019-01-04)Article de revue -
Empirical economic analysis of orphan drug legislation impact on innovation
GORRY, Philippe; USECHE, Diego; ZUMPE, Martin(Eur. Health Economic Association Conf., DE, Hamburg)Communication dans un congrès avec actes -
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies
USECHE, Diego; GORRY, Philippe(65th Annual Meeting of the French Economic Association,, FR, Nancy)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Empirical Economic Analysis of Orphan Drug Innovation
BENOIT, Cyril; GORRY, Philippe; USECHE, Diego ...(NBER Economic Dimensions of Personalized and Precision Medicine,, US, Santa Monica. CA,)Communication dans un congrès avec actes -
Empirical Economic Analysis of Orphan Drug Innovation
GORRY, Philippe; USECHE, Diego; ZUMPE, Martin(NBER Economic Dimensions of Personalized and Precision Medicine, Columbia Univ., US, New York)Communication dans un congrès avec actes -
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies
USECHE, Diego; GORRY, Philippe(DRUID Society Conf., DK, Copenhague)Communication dans un congrès avec actes -
Empirical Economic Analysis of Orphan DrugLegislation Impact on Innovation
GORRY, Philippe; USECHE, Diego; ZUMPE, Martin(European Health Economics Association Conference, DE, HAMBURG)Communication dans un congrès avec actes -
Empirical Economic Analysis ofOrphan Drug Innovation
GORRY, Philippe; BENOIT, Cyril; USECHE, Diego ...(NBER Conference : Economic Dimensions of Personalized and Precision Medecine, US, New York)Communication dans un congrès avec actes